BioSpace News Archive

Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of Alzheimer’s disease

CSI Laboratories (CSI) and Synergy Capital Investments (Synergy) announced the transition of a convertible note to equity stake in CSI, a state of the art, specialized cancer diagnostic center.

Consulting Hypnotists Help Ordinary People with Ordinary Problems

Sandoz is committed to helping people access high quality healthcare at affordable prices, with strong focus on areas of unmet patient need

Advarra is a leading provider of institutional review board, institutional biosafety committee and research quality and compliance services, which are mandated by regulatory agencies for all trial protocols, patient forms, site initiations and trial modifications.

Unprecedented effort to educate public about one of the world’s most common birth defects, and the growing number of treatment options available

Historically, pregnancy in patients with systemic lupus erythematosus was considered so risky that physicians counseled women to avoid becoming pregnant and recommended that women carrying a child terminate their pregnancy.

Otava, a global leader in secure cloud services for enterprise and channel partners, has been chosen by The Hospital Quality Institute to create and manage two comprehensive virtual private cloud environments for confidential data.

Trial will evaluate safety and efficacy of onvansertib plus FOLFIRI and Avastin® (bevacizumab) for treatment of patients with KRAS-mutated metastatic Colorectal Cancer (mCRC)

Strategic Investment Supports FMCNA’s Goal to Improve Monitoring, Interventions and Outcomes for Patients Living with Kidney Disease and Other Chronic Illnesses [09-July-2019] WALTHAM, Mass. , July 9, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the leading provider of kidney care products and services, announces a major strategic investment in